Schizophrenia
Conditions
Brief summary
Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual. \*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU. \*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.
Interventions
BEHAVIORALpsychodynamic art therapy
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
Sponsors
Prof. K. Dannecker, Kunsttherapie Berlin Kunsthochschule Berlin-Weißensee
Charite University, Berlin, Germany
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No
Inclusion criteria
* diagnosis of schizophrenia according to DSM-IV-TR * age 18-64 yrs * sufficient German language competency * written informed consent
Exclusion criteria
* axis-I mental disorders other than schizophrenia * comorbid antisocial personality disorder, relevant substance abuse, * relevant severe somatic disease * acute suicidal tendencies or aggression * incapability to tolerate group settings
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Positive and Negative Syndrome Scale (PANSS-) scores | weeks 0, 6, 12 | assessment of change of schizophrenic positive, negative and general symptom scores |
| safety measures | weeks 0, 6, 12 | number of participants with adverse events |
| Change in Calgary depression Scale (CDS-) scores | weeks 0, 6, 12 | assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores |
Countries
Germany
Outcome results
None listed